Escalation-level diagnostics
Immune & inflammation insight
Faster, safer recovery
Comprehensive Evaluation for Bronchitis, Pneumonia & Persistent Lower Respiratory Symptoms. Lower respiratory infections are fundamentally different from simple upper respiratory illnesses.
This panel is ideal for individuals with a persistent or worsening cough, mucus or sputum production, chest tightness or pain, shortness of breath, or fever lasting more than a few days. It is especially appropriate for patients who are not improving with initial treatment, have recurrent bronchitis or pneumonia, or require escalation beyond basic upper respiratory testing.
Basic respiratory testing often stops at upper airway viruses and delays escalation until symptoms worsen. This panel takes a comprehensive, escalation-level approach by evaluating lower airway pathogens, atypical infections, immune competence, inflammatory burden, and structural lung involvement in one coordinated workup. The result is faster clarity, safer treatment decisions, and reduced risk of complications.
This panel focuses on the lower airways and chest involvement, including sputum culture, advanced PCR testing, immune markers, and imaging coordination—elements not included in basic URI testing.
Results help assess severity and risk, supporting decisions about escalation of care, imaging follow-up, or hospital evaluation.
Absolutely. It is specifically designed for cases where first-line treatment has failed or symptoms are worsenin
Yes. Sputum testing, inflammatory markers, and chest imaging work together to confirm or rule out pneumonia and assess disease severity.
